Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of Last-line Treatment in Metastatic Breast Cancer.
Cinausero M, Gerratana L, De Carlo E, Iacono D, Bonotto M, Fanotto V, Buoro V, Basile D, Vitale MG, Rihawi K, Fasola G, Puglisi F. Cinausero M, et al. Clin Breast Cancer. 2018 Jun;18(3):205-213. doi: 10.1016/j.clbc.2017.07.008. Epub 2017 Jul 14. Clin Breast Cancer. 2018. PMID: 28781022
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins.
Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A. Rihawi K, et al. Among authors: cinausero m. J Thorac Oncol. 2018 Mar;13(3):e41-e43. doi: 10.1016/j.jtho.2017.10.024. J Thorac Oncol. 2018. PMID: 29472059 Free article. No abstract available.
Emerging therapies in malignant pleural mesothelioma.
Cinausero M, Rihawi K, Cortiula F, Follador A, Fasola G, Ardizzoni A. Cinausero M, et al. Crit Rev Oncol Hematol. 2019 Dec;144:102815. doi: 10.1016/j.critrevonc.2019.102815. Epub 2019 Oct 5. Crit Rev Oncol Hematol. 2019. PMID: 31670225 Review.
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.
Cinausero M, Laprovitera N, De Maglio G, Gerratana L, Riefolo M, Macerelli M, Fiorentino M, Porcellini E, Buoro V, Gelsomino F, Squadrilli A, Fasola G, Negrini M, Tiseo M, Ferracin M, Ardizzoni A. Cinausero M, et al. Ther Adv Med Oncol. 2019 Nov 14;11:1758835919885540. doi: 10.1177/1758835919885540. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31798692 Free PMC article.
Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis.
Bonotto M, Gerratana L, Di Maio M, De Angelis C, Cinausero M, Moroso S, Milano M, Stanzione B, Gargiulo P, Iacono D, Minisini AM, Mansutti M, Fasola G, De Placido S, Arpino G, Puglisi F. Bonotto M, et al. Among authors: cinausero m. Breast. 2017 Feb;31:114-120. doi: 10.1016/j.breast.2016.10.021. Epub 2016 Nov 9. Breast. 2017. PMID: 27837704 Free article.
The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.
Lisanti C, Basile D, Parnofiello A, Bertoli E, Andreotti VJ, Garattini SK, Bartoletti M, Cattaneo M, Di Nardo P, Bonotto M, Casagrande M, Da Ros L, Cinausero M, Foltran L, Pella N, Buonadonna A, Aprile G, Fasola G, Puglisi F. Lisanti C, et al. Among authors: cinausero m. J Geriatr Oncol. 2020 Nov;11(8):1268-1273. doi: 10.1016/j.jgo.2020.06.010. Epub 2020 Jun 21. J Geriatr Oncol. 2020. PMID: 32576519
Immunotherapy for older patients with melanoma: From darkness to light?
Iacono D, Vitale MG, Basile D, Pelizzari G, Cinausero M, Poletto E, Pascoletti G, Minisini AM. Iacono D, et al. Among authors: cinausero m. Pigment Cell Melanoma Res. 2021 May;34(3):550-563. doi: 10.1111/pcmr.12917. Epub 2020 Aug 18. Pigment Cell Melanoma Res. 2021. PMID: 32745351 Review.
43 results